Aluminum-based adjuvant particles (Alum)

Aluminum-based adjuvant particles, colloquially known as alum, are the most widely utilized adjuvants in human vaccinology and have been in clinical use for nearly a century. These particles, primarily composed of aluminum hydroxide or aluminum phosphate, function by enhancing the immunogenicity of co-administered vaccine antigens (HogenEsch, 2002). Their primary biological role is to stimulate a robust and long-lasting humoral immune response, characterized by high titers of protective antibodies. Alum achieves this by creating a localized depot for slow antigen release, recruiting inflammatory cells to the injection site, and activating the innate immune system via the NLRP3 inflammasome pathway (Marrack et al., 2009). While essential for the efficacy of vaccines against pathogens like Hepatitis B, HPV, and Tetanus, alum is also associated with localized inflammatory side effects such as nodules or granulomas (Kool et al., 2008). Despite their extensive history, the precise molecular interactions between aluminum particles and the host immune system remain a significant area of ongoing immunological research (Ghimire, 2015).

Other names

Aluminum hydroxideAluminum phosphatePotassium aluminum sulfateAlhydrogelAdju-PhosAmorphous aluminum hydroxyphosphate sulfateAlum

Aluminum-based adjuvants act through a multi-modal mechanism: 1) The depot effect, which sequesters antigens at the injection site for prolonged exposure to the immune system (HogenEsch, 2002); 2) Induction of local cell death and release of endogenous danger signals (DAMPs) such as uric acid and host DNA (Marrack et al., 2009); 3) Activation of the NLRP3 inflammasome, leading to the maturation and secretion of pro-inflammatory cytokines like IL-1β (Kool et al., 2008); and 4) Enhancement of antigen uptake and presentation by dendritic cells and other antigen-presenting cells, typically biasing the immune response toward a Th2 (humoral) profile (Ghimire, 2015).